Published in J Antimicrob Chemother on January 01, 2003
Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis (1994) 5.28
The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples. J Clin Microbiol (1992) 3.56
Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Düsseldorf area. J Antimicrob Chemother (1999) 3.42
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother (1998) 3.21
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe). Diagn Microbiol Infect Dis (1999) 3.11
Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect (2011) 2.83
Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol (2005) 2.56
Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis (2001) 2.39
Resistance integrons and super-integrons. Clin Microbiol Infect (2004) 2.24
Transmission of methicillin-resistant Staphylococcus aureus strains between different kinds of pig farms. Vet Microbiol (2007) 2.16
In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet (2001) 2.14
Methicillin-resistant staphylococci isolated from animals. Vet Microbiol (2004) 2.01
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol (1997) 1.90
Evaluation of the magnetic immuno PCR assay for rapid detection of Salmonella. Eur J Clin Microbiol Infect Dis (1991) 1.85
Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob Agents Chemother (2003) 1.76
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob Agents Chemother (1999) 1.75
The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother (1998) 1.71
Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group. J Antimicrob Chemother (1999) 1.69
Rapid detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases in Enterobacteriaceae using ligation-mediated amplification with microarray analysis. J Antimicrob Chemother (2010) 1.68
[Fatal pneumonia in an adolescent due to community-acquired methicillin-resistant Staphylococcus aureus positive for Panton-Valentine-leukocidin]. Ned Tijdschr Geneeskd (2003) 1.68
The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. J Antimicrob Chemother (1999) 1.68
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe. Antimicrob Agents Chemother (2007) 1.66
Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother (2001) 1.59
False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis (2004) 1.57
Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology (2005) 1.56
Antibiotics and phagocytosis. Eur J Clin Microbiol (1983) 1.56
Development of resistance during antibiotic therapy. Eur J Clin Microbiol (1987) 1.51
Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates. FEMS Immunol Med Microbiol (1999) 1.51
Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. FEMS Microbiol Lett (1998) 1.48
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 1.48
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.48
Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol (2002) 1.46
Short term micro-evolution and PCR-detection of methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398. Eur J Clin Microbiol Infect Dis (2009) 1.42
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Eur J Clin Microbiol Infect Dis (2000) 1.42
Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis. Eur J Clin Microbiol Infect Dis (1998) 1.42
Rapid identification of bacteria by PCR-single-strand conformation polymorphism. J Clin Microbiol (1994) 1.41
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother (2000) 1.40
Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene. J Clin Microbiol (1995) 1.38
Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.35
A set of multiplex PCRs for genotypic detection of extended-spectrum β-lactamases, carbapenemases, plasmid-mediated AmpC β-lactamases and OXA β-lactamases. Int J Antimicrob Agents (2011) 1.34
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. J Clin Microbiol (2000) 1.32
Novel gene cassettes and integrons. Antimicrob Agents Chemother (2001) 1.31
mecA gene is widely disseminated in Staphylococcus aureus population. J Clin Microbiol (2002) 1.30
Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol (2003) 1.29
Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit. J Hosp Infect (2002) 1.29
Methicillin-resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks. Vet Microbiol (2009) 1.25
Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in methicillin-resistant Staphylococcus aureus CC398 isolates. Antimicrob Agents Chemother (2010) 1.24
Increased prevalence of class I integrons in Escherichia coli, Klebsiella species, and Enterobacter species isolates over a 7-year period in a German university hospital. J Clin Microbiol (2001) 1.23
In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates. Antimicrob Agents Chemother (2000) 1.23
Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents (2003) 1.22
Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates. J Antimicrob Chemother (2001) 1.22
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents (2004) 1.20
NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol (2009) 1.20
Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay. J Clin Microbiol (1994) 1.19
Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing. Eur J Clin Microbiol Infect Dis (2011) 1.18
Fluoroquinolones: structure and target sites. Curr Drug Targets (2003) 1.17
In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis (2003) 1.16
Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci. Eur J Clin Microbiol Infect Dis (2000) 1.15
Clindamycin enhances opsonization of Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.14
A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect (2013) 1.13
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother (2005) 1.13
Susceptibility of 302 methicillin-resistant Staphylococcus aureus isolates from 20 European university hospitals to vancomycin and alternative antistaphylococcal compounds. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis (1999) 1.12
Monoclonal antibodies that react with live Listeria spp. Appl Environ Microbiol (1993) 1.12
Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother (2000) 1.09
In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob Agents Chemother (2001) 1.08
Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping. J Clin Microbiol (2000) 1.07
Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis (1999) 1.07
Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother (2006) 1.07
Transmission of methicillin-resistant Staphylococcus intermedius between humans and animals. Vet Microbiol (2007) 1.06
Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance. Eur J Clin Microbiol Infect Dis (2002) 1.03
Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers. Eur J Clin Microbiol (1987) 1.02
Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Antimicrob Agents Chemother (1999) 1.02
An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol (2007) 1.01
Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill (2014) 1.00
Monoclonal antibodies that detect live salmonellae. Appl Environ Microbiol (1992) 1.00
Comparison of typing methods for Clostridium difficile isolates. J Clin Microbiol (1993) 1.00
Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group. Eur J Clin Microbiol Infect Dis (1999) 0.99
Genetic relatedness of multidrug-resistant, methicillin (oxacillin)-resistant Staphylococcus aureus bloodstream isolates from SENTRY Antimicrobial Resistance Surveillance Centers worldwide, 1998. Microb Drug Resist (2000) 0.99
Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? Eur J Clin Microbiol (1986) 0.96
Intraphagocytic activity of ciprofloxacin and CI 934. Eur J Clin Microbiol (1986) 0.95
Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA). Diagn Microbiol Infect Dis (2001) 0.94
Pharmacokinetics and absolute bioavailability of sitafloxacin, a new fluoroquinolone antibiotic, in healthy male and female Caucasian subjects. Xenobiotica (2001) 0.94
Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res (2005) 0.94
Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species. J Microbiol Methods (1999) 0.93
Control of nosocomial multiresistant Enterobacteriaceae using a temporary restrictive antibiotic agent policy. Eur J Clin Microbiol Infect Dis (2001) 0.93
Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation. J Virol (1988) 0.92
Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates. Int J Antimicrob Agents (2001) 0.92
Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (1995) 0.92
Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis. Vet Microbiol (2008) 0.90
Seizure-induced changes in energy metabolites and effects of N-tert-butyl-alpha-phenylnitrone (PNB) and vitamin E in rats. Pflugers Arch (2000) 0.90
Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch Virol (1989) 0.90